AAPL334.19+7.62 (+2.33%) ▲|ABBV257.58+2.58 (+1.01%) ▲|ABT102.30-1.07 (-1.03%) ▼|ACN181.42+3.51 (+1.97%) ▲|ADBE253.84+5.01 (+2.01%) ▲|AMAT461.61+7.60 (+1.67%) ▲|AMD515.91+12.31 (+2.44%) ▲|AMGN379.07-3.40 (-0.89%) ▼|AMT178.40+5.42 (+3.13%) ▲|AMZN256.82+4.93 (+1.96%) ▲|AVGO364.95+4.12 (+1.14%) ▲|AXP325.17+4.46 (+1.39%) ▲|BA210.76+5.96 (+2.91%) ▲|BAC62.93+0.37 (+0.59%) ▲|BKNG174.68+0.77 (+0.44%) ▲|BLK1,086.52+24.12 (+2.27%) ▲|BMY63.43-0.32 (-0.50%) ▼|BNY162.91+0.32 (+0.20%) ▲|BRK-B507.30+0.30 (+0.06%) ▲|C138.88+0.38 (+0.27%) ▲|CAT821.98+16.98 (+2.11%) ▲|CL87.62-0.28 (-0.32%) ▼|CMCSA25.27+0.10 (+0.38%) ▲|COF208.13+1.02 (+0.49%) ▲|COP136.51-0.53 (-0.39%) ▼|COST904.23+1.85 (+0.21%) ▲|CRM248.79+5.79 (+2.38%) ▲|CSCO111.61+4.17 (+3.88%) ▲|CVS94.34-0.96 (-1.00%) ▼|CVX213.94+1.18 (+0.55%) ▲|DE681.57+3.63 (+0.54%) ▲|DHR200.99+0.46 (+0.23%) ▲|DIS106.61+0.79 (+0.74%) ▲|DUK119.78+0.41 (+0.34%) ▲|EMR151.69+3.32 (+2.24%) ▲|FDX312.90+1.10 (+0.35%) ▲|GD357.12+2.87 (+0.81%) ▲|GE325.80+1.65 (+0.51%) ▲|GEV952.55+28.64 (+3.10%) ▲|GILD144.01-0.80 (-0.55%) ▼|GM86.45+0.33 (+0.38%) ▲|GOOG337.69+7.30 (+2.21%) ▲|GOOGL340.72+8.12 (+2.44%) ▲|GS1,031.89+12.12 (+1.19%) ▲|HD309.43+3.74 (+1.22%) ▲|HON202.80+0.62 (+0.30%) ▲|IBM240.68+6.66 (+2.85%) ▲|INTC103.37+3.05 (+3.04%) ▲|INTU320.00+7.23 (+2.31%) ▲|ISRG367.90+7.44 (+2.06%) ▲|JNJ265.75-0.61 (-0.23%) ▼|JPM356.59+3.03 (+0.86%) ▲|KO88.28+0.45 (+0.51%) ▲|LIN467.02+5.40 (+1.17%) ▲|LLY1,122.11-0.90 (-0.08%) ▼|LMT525.69-4.43 (-0.84%) ▼|LOW198.13+1.54 (+0.78%) ▲|LRCX301.69+3.68 (+1.23%) ▲|MA569.53+4.16 (+0.74%) ▲|MCD253.43+0.38 (+0.15%) ▲|MDLZ62.56+0.09 (+0.14%) ▲|MDT90.62-1.00 (-1.09%) ▼|META650.18+5.80 (+0.90%) ▲|MMM165.16+2.30 (+1.41%) ▲|MO69.10+0.31 (+0.45%) ▲|MRK145.37+0.66 (+0.45%) ▲|MS214.53+1.87 (+0.88%) ▲|MSFT495.34+2.90 (+0.59%) ▲|MU978.14+0.73 (+0.07%) ▲|NEE82.90+0.46 (+0.56%) ▲|NFLX77.06+1.05 (+1.37%) ▲|NKE36.94+0.32 (+0.87%) ▲|NOW132.97+1.80 (+1.37%) ▲|NVDA219.32+0.96 (+0.44%) ▲|ORCL152.94+0.00 (+0.00%) ▲|PEP137.04+0.39 (+0.29%) ▲|PFE27.61-0.05 (-0.16%) ▼|PG145.39+2.42 (+1.69%) ▲|PLTR167.09+1.23 (+0.74%) ▲|PM193.15+3.38 (+1.78%) ▲|QCOM185.31+8.43 (+4.76%) ▲|RTX198.37+0.25 (+0.13%) ▲|SBUX99.00-0.22 (-0.22%) ▼|SCHW106.81-0.53 (-0.49%) ▼|SO88.01+0.26 (+0.30%) ▲|SPG205.14+0.47 (+0.23%) ▲|T26.16+0.61 (+2.39%) ▲|TMO612.04+8.86 (+1.47%) ▲|TMUS183.56+6.40 (+3.61%) ▲|TSLA366.21+2.65 (+0.73%) ▲|TXN271.95+13.13 (+5.07%) ▲|UBER71.92-0.64 (-0.88%) ▼|UNH378.35-9.93 (-2.56%) ▼|UNP284.26-1.53 (-0.53%) ▼|UPS100.12+0.15 (+0.15%) ▲|USB62.83+0.42 (+0.67%) ▲|V371.12+3.91 (+1.06%) ▲|VZ50.63+0.66 (+1.32%) ▲|WFC90.52+1.07 (+1.19%) ▲|WMT106.62+0.89 (+0.84%) ▲|XOM165.55+0.32 (+0.19%) ▲|AAPL334.19+7.62 (+2.33%) ▲|ABBV257.58+2.58 (+1.01%) ▲|ABT102.30-1.07 (-1.03%) ▼|ACN181.42+3.51 (+1.97%) ▲|ADBE253.84+5.01 (+2.01%) ▲|AMAT461.61+7.60 (+1.67%) ▲|AMD515.91+12.31 (+2.44%) ▲|AMGN379.07-3.40 (-0.89%) ▼|AMT178.40+5.42 (+3.13%) ▲|AMZN256.82+4.93 (+1.96%) ▲|AVGO364.95+4.12 (+1.14%) ▲|AXP325.17+4.46 (+1.39%) ▲|BA210.76+5.96 (+2.91%) ▲|BAC62.93+0.37 (+0.59%) ▲|BKNG174.68+0.77 (+0.44%) ▲|BLK1,086.52+24.12 (+2.27%) ▲|BMY63.43-0.32 (-0.50%) ▼|BNY162.91+0.32 (+0.20%) ▲|BRK-B507.30+0.30 (+0.06%) ▲|C138.88+0.38 (+0.27%) ▲|CAT821.98+16.98 (+2.11%) ▲|CL87.62-0.28 (-0.32%) ▼|CMCSA25.27+0.10 (+0.38%) ▲|COF208.13+1.02 (+0.49%) ▲|COP136.51-0.53 (-0.39%) ▼|COST904.23+1.85 (+0.21%) ▲|CRM248.79+5.79 (+2.38%) ▲|CSCO111.61+4.17 (+3.88%) ▲|CVS94.34-0.96 (-1.00%) ▼|CVX213.94+1.18 (+0.55%) ▲|DE681.57+3.63 (+0.54%) ▲|DHR200.99+0.46 (+0.23%) ▲|DIS106.61+0.79 (+0.74%) ▲|DUK119.78+0.41 (+0.34%) ▲|EMR151.69+3.32 (+2.24%) ▲|FDX312.90+1.10 (+0.35%) ▲|GD357.12+2.87 (+0.81%) ▲|GE325.80+1.65 (+0.51%) ▲|GEV952.55+28.64 (+3.10%) ▲|GILD144.01-0.80 (-0.55%) ▼|GM86.45+0.33 (+0.38%) ▲|GOOG337.69+7.30 (+2.21%) ▲|GOOGL340.72+8.12 (+2.44%) ▲|GS1,031.89+12.12 (+1.19%) ▲|HD309.43+3.74 (+1.22%) ▲|HON202.80+0.62 (+0.30%) ▲|IBM240.68+6.66 (+2.85%) ▲|INTC103.37+3.05 (+3.04%) ▲|INTU320.00+7.23 (+2.31%) ▲|ISRG367.90+7.44 (+2.06%) ▲|JNJ265.75-0.61 (-0.23%) ▼|JPM356.59+3.03 (+0.86%) ▲|KO88.28+0.45 (+0.51%) ▲|LIN467.02+5.40 (+1.17%) ▲|LLY1,122.11-0.90 (-0.08%) ▼|LMT525.69-4.43 (-0.84%) ▼|LOW198.13+1.54 (+0.78%) ▲|LRCX301.69+3.68 (+1.23%) ▲|MA569.53+4.16 (+0.74%) ▲|MCD253.43+0.38 (+0.15%) ▲|MDLZ62.56+0.09 (+0.14%) ▲|MDT90.62-1.00 (-1.09%) ▼|META650.18+5.80 (+0.90%) ▲|MMM165.16+2.30 (+1.41%) ▲|MO69.10+0.31 (+0.45%) ▲|MRK145.37+0.66 (+0.45%) ▲|MS214.53+1.87 (+0.88%) ▲|MSFT495.34+2.90 (+0.59%) ▲|MU978.14+0.73 (+0.07%) ▲|NEE82.90+0.46 (+0.56%) ▲|NFLX77.06+1.05 (+1.37%) ▲|NKE36.94+0.32 (+0.87%) ▲|NOW132.97+1.80 (+1.37%) ▲|NVDA219.32+0.96 (+0.44%) ▲|ORCL152.94+0.00 (+0.00%) ▲|PEP137.04+0.39 (+0.29%) ▲|PFE27.61-0.05 (-0.16%) ▼|PG145.39+2.42 (+1.69%) ▲|PLTR167.09+1.23 (+0.74%) ▲|PM193.15+3.38 (+1.78%) ▲|QCOM185.31+8.43 (+4.76%) ▲|RTX198.37+0.25 (+0.13%) ▲|SBUX99.00-0.22 (-0.22%) ▼|SCHW106.81-0.53 (-0.49%) ▼|SO88.01+0.26 (+0.30%) ▲|SPG205.14+0.47 (+0.23%) ▲|T26.16+0.61 (+2.39%) ▲|TMO612.04+8.86 (+1.47%) ▲|TMUS183.56+6.40 (+3.61%) ▲|TSLA366.21+2.65 (+0.73%) ▲|TXN271.95+13.13 (+5.07%) ▲|UBER71.92-0.64 (-0.88%) ▼|UNH378.35-9.93 (-2.56%) ▼|UNP284.26-1.53 (-0.53%) ▼|UPS100.12+0.15 (+0.15%) ▲|USB62.83+0.42 (+0.67%) ▲|V371.12+3.91 (+1.06%) ▲|VZ50.63+0.66 (+1.32%) ▲|WFC90.52+1.07 (+1.19%) ▲|WMT106.62+0.89 (+0.84%) ▲|XOM165.55+0.32 (+0.19%) ▲|
26.7 C
New York
Friday, September 11, 2026

Tag: report

newssourceFORcompanyinformationcontent1releasesmarket

New Class, New Conversations: What Incoming Freshmen Want Colleges to Know

TimelyCare Report: 65% of Students Have Already Been to Therapy Before Starting College, 83% Expect Campus Mental Health Support FORT WORTH, Texas, Aug. 11, 2025 /PRNewswire/...

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public.

Investor Alert: Dominion Peak falsely implies CIRO registration

Be an informed investor - Protect yourself against fraudulent schemes TORONTO, Aug. 11, 2025 /CNW/ - The Canadian Investment Regulatory Organization (CIRO) is warning investors...

Beauty and Personal Care Market Thrives Across the MENA Region

"With growing interest in self-care, halal beauty products, and online shopping, countries like Saudi Arabia, the UAE, Egypt, and Iran are becoming major hubs...

Manufacturers Urged to Act With Technology-First Plans as Disruption Intensifies, Says Info-Tech Research Group in New Report

With volatility across supply chains, energy markets, and labor, manufacturing CIOs are being pushed beyond traditional cost containment strategies to enable rapid digital transformation...

Manufacturers Urged to Act With Technology-First Plans as Disruption Intensifies, Says Info-Tech Research Group in New Report

With volatility across supply chains, energy markets, and labor, manufacturing CIOs are being pushed beyond traditional cost containment strategies to enable rapid digital transformation...

Winnebago Industries Announces Strategic Leadership Changes to Drive Future Growth

Group Business Leaders Established; Functional Leaders Responsibilities Enhanced

Booking Health Unveils New Study: Role of Immunotherapy in Extending Life Expectancy for Stage4 Cervical Cancer Patients

Langenfeld, Germany, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global leader in medical treatment coordination, today unveiled a new study titled Role of Immunotherapy in Extending Life Expectancy for Stage 4 Cervical Cancer Patients. The report outlines how cutting-edge immunotherapy is reshaping care for women with advanced cervical cancer, offering new pathways to longer survival and improved quality of life, particularly in cases resistant to standard treatments.

REPEAT — Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion...

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced its top-line revenue forecast for its specialty care pipeline, projecting nearly $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $18 billion and $22 billion. This forecast reflects the company’s unique, faster, and cost-efficient drug development model which has the potential to serve as a blueprint to ensure sustainable medical innovation for years to come.

BreachLock’s 2025 Pentesting Intelligence Report Analyzes 4,200+ Pentests, Reveals Today’s Most Critical Risk Patterns

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- BreachLock's 2025 Penetration Testing Intelligence Report, released today, analyzes over 4,200 pentests conducted over the past 12...

Microgrid Market to Grow at a CAGR of 15.6% from 2025 to 2032 | SkyQuest Technology Consulting

The global microgrid market is witnessing rapid growth, primarily driven by the rising demand for energy resilience and reliability, especially in the face of grid...

Microgrid Market to Grow at a CAGR of 15.6% from 2025 to 2032 | SkyQuest Technology Consulting

The global microgrid market is witnessing rapid growth, primarily driven by the rising demand for energy resilience and reliability, especially in the face of grid...

ESPN DTC AND FOX ONE TO LAUNCH COMBINED BUNDLE OFFER

Viewers will have the opportunity to bundle ESPN's DTC Unlimited Offering and FOX One for $39.99 per month Starting October 2 BRISTOL, Conn. and LOS...

Smart Textiles Market worth $5.56 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 11, 2025 /PRNewswire/ -- The smart textiles market is projected to grow from USD 2.41 billion in 2025 to USD 5.56...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReport

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers